B-cell development

Last updated: November 01, 2022

B-cell development

Watch later

Watch later

B-cell development
B-cell activation, differentiation, and contraction
T-cell development
T-cell activation
Antibody classes
Acyanotic congenital heart defects: Pathology review
MEN syndromes: Clinical
Renal failure: Pathology review
Electrolyte disturbances: Pathology review
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Renal and urinary tract masses: Pathology review
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Chronic kidney disease
Amenorrhea: Pathology review
Vaginal and vulvar disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Breast cancer: Pathology review
Benign breast conditions: Pathology review
Cervical cancer: Pathology review
Uterine disorders: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Appendicitis: Pathology review
Colorectal polyps and cancer: Pathology review
Gallbladder disorders: Pathology review
Pancreatic cancer
Chronic pancreatitis
Pancreatic pseudocyst
Gallbladder carcinoma
Cholangiocarcinoma
Hepatocellular carcinoma
Benign liver tumors
Bacillus cereus (Food poisoning)
Salmonella (non-typhoidal)
Diarrhea: Clinical
Norovirus
Poliovirus
Pseudomonas aeruginosa
Salmonella typhi (typhoid fever)
Atrioventricular block
Bundle branch block
Ischemic stroke
Intracerebral hemorrhage
Epidural hematoma
Subdural hematoma
Subarachnoid hemorrhage
Alzheimer disease
Vascular dementia
Frontotemporal dementia
Dementia with Lewy bodies
Parkinson disease
Multiple sclerosis
Adult brain tumors
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Back pain: Pathology review
Seronegative and septic arthritis: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Bone tumors: Pathology review
Neuromuscular junction disorders: Pathology review
Pediatric musculoskeletal disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Myalgias and myositis: Pathology review
Bone disorders: Pathology review
Scleroderma: Pathology review
Gout and pseudogout: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review

Transcript

Watch video only

Your immune system is like the military - with two main branches, the innate immune response and the adaptive immune response.

The innate immune response is immediate and non-specific, meaning that although it can distinguish an invader from a human cell, it doesn’t distinguish one invader from another invader.

In contrast, the adaptive immune response is highly specific for each invader, and that’s because the cells of the adaptive immune response have receptors that differentiate friendly bacteria and potentially deadly ones from their unique parts - called antigens.

This adaptive immune response takes days to weeks to become activated, but is also responsible for immunologic memory.

Now, the key cells of the adaptive immune response are the lymphocytes- the B and T cells -which are generated during lymphopoiesis.

Lymphopoiesis has three goals - first, to generate a diverse set of lymphocytes - each with a unique antigen receptor, second, to get rid of lymphocytes that have receptors that are self-reactive meaning that they’ll bind to healthy tissue, and third, to allow lymphocytes that aren’t self-reactive to continue maturing in secondary lymphoid tissue.

Normally, hematopoietic stem cells, within the bone marrow mature into a common lymphoid progenitor cell, which then becomes either a B-cell or a T-cell.

To become a B cell, it has to develop into an immature B-cell in the bone marrow and then complete its maturation into an antibody secreting B cell, called a plasma cell, in the lymph nodes and spleen.

To become a T cell, it has to migrate to the thymus and become a thymocyte, where it completes its development into a mature T cell.

So, “B” for bone marrow and “T” for thymus.

Throughout B cell development, the developing cells are interacting closely with the stromal cells of the bone marrow, which are largely composed of mesenchymal stem cells.

Mesenchymal cells are multipotent and can differentiate into various cells including macrophages and endothelial cells.

Mesenchymal cells provide B cell with adhesion molecules they can use to attach and important growth factors like interleukin 7, they can use to grow and proliferate.

As they develop, B cells go through 6 stages: They start as common lymphoid progenitor cells, then become early pro-B cells, then late pro-B cells, then large pre-b cells, then small pre-B cells, and finally immature B cells.

As the cell develops it makes permanent changes in its DNA so that by the time it’s an immature B cell it has DNA that uniquely codes for a B cell receptor that can bind to foreign antigens but isn’t self-reactive.

The B cell receptor has two chains, a heavy chain and a light chain.

The heavy chain contains regions that determine the type of antibody it will become as well as whether the B cell receptor will be surface bound or secreted, like an antibody.

The region where the heavy chain and light chain come together form a unique protein structure capable of binding proteins, carbohydrates, or lipids that the B cell might eventually encounter - and this is called the antigen binding site.

The antigen binding site of the B cell receptor is made up of three protein segments that are called V for variable, D for diversity, and J for joining.

The heavy chain is made up of 1 V segment, 1 D segment, and 1 J segment; while the light chain only contains a V and J segment - this is easy to remember - just think of it as the extra segment making the heavy chain heavier.

Every person inherits multiple genes that encode the V, D, and J protein segments, and these segments can be mixed and matched to make a unique structure.

A bit like how you might have several pairs of shoes, pants, and shirts and can mix and match them to create lots of different outfit combinations.

For the heavy chain, each person has 44 V gene segments, 27 D segments, and 6 J segments! And there are even more V and J segments for the light chain.

So one B cell might have a B cell receptor with a heavy chain that has a VH1-DH3-JH5 combination and a light chain that’s VL7-JL2, and another B cell might have a B cell receptor with a heavy chain that has a VH44-DH10-JH1 combination and a light chain that’s VL2-JL3.

And that would mean that these two B-cells would have completely different B cell receptors and therefore different antigen specificities.

Now, to have a fully functioning B cell receptor, a B cell has to get through a series of successful gene rearrangements, first for the heavy chain and then the light chain. And if the B cell fails at any stage, it dies!

It all starts with a common lymphoid progenitor cell which has various V, D, and J gene segments all lined up in its germline DNA.

Two enzymes, Rag-1 and Rag-2, start getting expressed, and that signifies that the cell is now an early pro-B cell.

Rag-1 and Rag-2 help to splice together D and J segments on both chromosomes, and the chromosome that successfully rearranges first will then suppress the other chromosome from rearranging - a process called allelic exclusion.

If a cell successfully joins a D segment to a J segment, then it’s considered a late pro-B cell.

Next, the late pro-B cell has to attach its D-J gene segment to a V gene segment, with the help of an additional enzyme called V(D)J recombinase.

Once the VDJ segment are combined, the full heavy chain’s antigen binding site is complete and needs to be recombined with the mu gene, which codes for the constant region of the antibody. T

he mu gene codes for the protein that makes the IgM constant region and it’s the first of the different types of antibody constant regions that are expressed on B cells.

Key Takeaways

B-cell development consists of a series of cellular transitions, from hematopoietic stem cells into immunocompetent B cells. Depending on the step, these processes take place in different organs namely the bone marrow, lymph nodes, and spleen.

Like any other type of blood cell, B cells originate from hematopoietic stem cells (HSCs). HSCs give rise to common lymphoid progenitor cells, which in their turn become either B-cells or T-cells. B cell development takes place in a series of six main stages. First, they start as common lymphoid progenitor cells, which become early pro-B cells, then late pro-B cells, next large pre-B cells, then small pre-B cells, and finally, immature B cells. Immature B cells then migrate from the bone marrow into the lymph nodes and spleen to complete the process of maturation.